Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co., Ltd., commonly referred to as Tasly, is a leading player in the pharmaceutical industry, headquartered in China (CN). Founded in 1994, the company has established a strong presence in both domestic and international markets, with significant operations across Asia, Europe, and North America. Specialising in traditional Chinese medicine and modern pharmaceuticals, Tasly is renowned for its innovative products, including herbal remedies and cardiovascular treatments. The company’s commitment to research and development has led to numerous breakthroughs, positioning it as a pioneer in integrating traditional practices with contemporary science. With a robust market presence, Tasly has achieved notable milestones, including multiple certifications for its quality management systems. Its dedication to enhancing health and well-being through unique, effective solutions continues to solidify its reputation as a trusted name in the global healthcare landscape.
DitchCarbon Score
How does Tasly Pharmaceutical Group Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tasly Pharmaceutical Group Co., Ltd's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tasly Pharmaceutical Group Co., Ltd's reported carbon emissions
Tasly Pharmaceutical Group Co., Ltd, headquartered in CN, currently does not have publicly available data on its carbon emissions, including specific figures for Scope 1, 2, or 3 emissions. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. Tasly may be engaging in similar initiatives, but without concrete information, it is difficult to assess their current climate impact or future commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tasly Pharmaceutical Group Co., Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
